Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Ranging Study of Lutein Supplementation
NCT00006202Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Sep 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lutein in age-related macular degeneration (AMD), sponsored by National Eye Institute. Started Sep 2000; status: completed.
02
Drugs
lutein
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00006202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006202.